Joel Walder

Joel Walder currently serves as the Market Access Manager for Astellas Pharma in the Alpine region, where he plays a pivotal role in shaping the company's strategic approach to market access, pricing, and reimbursement within Switzerland and Austria. Leveraging his extensive expertise in health economics and outcomes research (HEOR), he is instrumental in developing evidence-based strategies that facilitate timely patient access to innovative therapies. His deep understanding of pharmaceutical pricing policies, health technology assessments (HTA), and pharmaceutical economics enables him to navigate complex regulatory landscapes and engage effectively with payers, policymakers, and healthcare stakeholders.

In his role, Joel leads key projects focused on optimizing market access pathways for Astellas’ portfolio, ensuring alignment with evolving healthcare policies and reimbursement frameworks. He collaborates closely with cross-functional teams—including medical affairs, commercial, and government affairs—to develop compelling value dossiers and pricing strategies that demonstrate the clinical and economic benefits of Astellas’ medicines. His background in management consulting at KPMG has further strengthened his ability to analyze market dynamics and develop innovative solutions tailored to the unique needs of the Swiss and Austrian healthcare markets.

Joel’s expertise in pharmaceutical pricing policies (Preispolitik), pharmacy economics (Pharmakoökonomie), and pricing & reimbursement (P&R) positions him as a key contributor to Astellas’ efforts to improve patient access while maintaining sustainable commercial growth. His strategic insights and stakeholder engagement skills are vital in advancing the company’s mission to deliver impactful therapies to patients across the Alpine region, making him a valuable asset in the ever-evolving landscape of market access and healthcare policy.